These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12707112)

  • 1. Lentiginous eruption due to topical immunotherapy.
    Tosti A; Piraccini BM; Misciali C; Vincenzi C
    Arch Dermatol; 2003 Apr; 139(4):544-5. PubMed ID: 12707112
    [No Abstract]   [Full Text] [Related]  

  • 2. [Squaric acid dibutyl ester in the treatment of severe alopecia areata].
    Miranda A; Mato F; Quiñones PA
    Med Cutan Ibero Lat Am; 1984; 12(3):273-8. PubMed ID: 6384701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of topical sensitizers in the treatment of alopecia areata.
    Rokhsar CK; Shupack JL; Vafai JJ; Washenik K
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):751-61. PubMed ID: 9810892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.
    Shimaoka Y; Hatamochi A; Hamasaki Y; Suzuki H; Ikeda H; Yamazaki S
    J Dermatol; 2008 Mar; 35(3):151-3. PubMed ID: 18346258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged dermatitis distant to the site of squaric acid dibutyl ester applications and recovery of alopecia areata.
    Ujiie H; Sawamura D; Shibaki A; Shimizu H
    Clin Exp Dermatol; 2005 Sep; 30(5):579-80. PubMed ID: 16045698
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of alopecia areata with topical sensitizers.
    Sutherland L; Laschinger M; Syed ZU; Gaspari A
    Dermatitis; 2015; 26(1):26-31. PubMed ID: 25581667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythema multiforme-like eruptions: a rare side effect of topical immunotherapy with diphenylcyclopropenone.
    Perret CM; Steijlen PM; Zaun H; Happle R
    Dermatologica; 1990; 180(1):5-7. PubMed ID: 2137800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side-effects during treatment with SADBE.
    Frattasio A; Germino M; Cargnello S; Patrone P
    Contact Dermatitis; 1997 Feb; 36(2):118-9. PubMed ID: 9062760
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pigmentation abnormalities in the course of topical immunotherapy of alopecia areata].
    Valsecchi R; Pansera B; Rossi A; Cainelli T
    G Ital Dermatol Venereol; 1989; 124(1-2):31-2. PubMed ID: 2527809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of the topical sensitizer squaric acid dibutyl ester in Alopecia areata and factors influencing the outcome.
    Ajith C; Gupta S; Kanwar AJ
    J Drugs Dermatol; 2006 Mar; 5(3):262-6. PubMed ID: 16573260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Questions raised by skin reactions observed during squaric acid dibutyl ester contact sensitization.
    Stinco G; Patrone P
    Contact Dermatitis; 2000 Jul; 43(1):52-3. PubMed ID: 10902598
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of alopecia areata with squaric acid dibutylester.
    Hill ND; Bunata K; Hebert AA
    Clin Dermatol; 2015; 33(3):300-4. PubMed ID: 25889130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymopentin in the treatment of alopecia areata.
    Orecchia G
    Dermatologica; 1989; 178(4):231. PubMed ID: 2670621
    [No Abstract]   [Full Text] [Related]  

  • 14. Topical sensitizers in alopecia areata.
    McMichael AJ; Henderson RL
    Dermatol Nurs; 2004 Aug; 16(4):333-6. PubMed ID: 15471045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical immunomodulator therapy with squaric acid dibutylester (SADBE) is effective treatment for severe alopecia areata (AA): results of an open-label, paired-comparison, clinical trial.
    Dall'oglio F; Nasca MR; Musumeci ML; La Torre G; Ricciardi G; Potenza C; Micali G
    J Dermatolog Treat; 2005 Feb; 16(1):10-4. PubMed ID: 15897160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fexofenadine hydrochloride enhances the efficacy of contact immunotherapy for extensive alopecia areata: Retrospective analysis of 121 cases.
    Inui S; Nakajima T; Toda N; Itami S
    J Dermatol; 2009 Jun; 36(6):323-7. PubMed ID: 19500180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Controlled study of the efficacy of topical immunotherapy in alopecia areata: squaric acid versus placebo].
    Pigatto PD; Rapisarda R; Polenghi MM; Altomare GF
    G Ital Dermatol Venereol; 1987 Dec; 122(12):667-70. PubMed ID: 3329149
    [No Abstract]   [Full Text] [Related]  

  • 18. Alopecia areata triggered or exacerbated by swine flu virus infection.
    Ito T; Tokura Y
    J Dermatol; 2012 Oct; 39(10):863-4. PubMed ID: 22142460
    [No Abstract]   [Full Text] [Related]  

  • 19. [Alopecia areata; pathogenesis and topical immunotherapy].
    Perret CM; Steijlen PM; Happle R
    Ned Tijdschr Geneeskd; 1989 Jun; 133(25):1256-60. PubMed ID: 2666865
    [No Abstract]   [Full Text] [Related]  

  • 20. Patterns of hair regrowth in alopecia areata.
    Orecchia G; Rabbiosi G
    Dermatologica; 1988; 176(5):270-2. PubMed ID: 3384153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.